Distinguished in Liver Spots

Dr. Fasahat Hamzavi

Dermatology
Hamzavi Pharmacy
2950 Keewahdin Rd, 
Fort Gratiot, MI 

Distinguished in Liver Spots
Hamzavi Pharmacy
2950 Keewahdin Rd, 
Fort Gratiot, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fasahat Hamzavi is a Dermatologist in Fort Gratiot, Michigan. Dr. Hamzavi is rated as a Distinguished provider by MediFind in the treatment of Liver Spots. His top areas of expertise are Universal Acquired Melanosis, Liver Spots, Actinic Keratosis, and Warts.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in MI
Hospital Affiliations
Mclaren Port Huron
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Hamzavi Pharmacy
2950 Keewahdin Rd, Fort Gratiot, MI 48059
Call: 810-455-1600

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Safety and Effect of LEO 90100 Aerosol Foam on the HPA Axis and Calcium Metabolism in Adolescent Subjects (Aged 12 to < 17 Years) With Plaque Psoriasis
Enrollment Status: Completed
Publish Date: March 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Completed
Publish Date: January 31, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE AD2) - A Phase 3, Double-Blind, Randomized, 8-Week, Vehicle-Controlled Efficacy and Safety Study of Ruxolitinib Cream Followed by a Long-Term Safety Extension Period in Adolescents and Adults With Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Combination product
Study Phase: Phase 3
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Enrollment Status: Completed
Publish Date: June 04, 2019
Intervention Type: Other, Biological
Study Phase: Phase 2
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
A Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study Evaluating the Efficacy and Safety of Once Weekly High Dose Oral Finasteride in the Treatment of Severe Nodulocystic Acne
Enrollment Status: Completed
Publish Date: February 15, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

1 Total Publications

Neonatal dermatophytosis: report of a case and review of the literature.
Neonatal dermatophytosis: report of a case and review of the literature.
Journal: Pediatric dermatology
Published: April 21, 2011
Similar Doctors
Advanced in Liver Spots
Dr. Fred Novice
Dermatology
Advanced in Liver Spots
Dr. Fred Novice
Dermatology

Fred M Novice MD Dermpath Lab

4120 W Maple Rd Ste 206, 
Bloomfield Hills, MI 
 (17.0 miles away)
248-932-3376
Experience:
43+ years
Languages Spoken:
English
See accepted insurances

Fred Novice is a Dermatologist in Bloomfield Hills, Michigan. Dr. Novice has been practicing medicine for over 43 years and is rated as a Distinguished provider by MediFind in the treatment of Liver Spots. His top areas of expertise are Epidermodysplasia Verruciformis, Epidermoid Cyst, Warts, and Eosinophilic Pustular Folliculitis.

Julie Byrd
Advanced in Liver Spots
Dr. Julie Byrd
Dermatology
Advanced in Liver Spots
Dr. Julie Byrd
Dermatology

Rochester Surgery Center

405 Barclay Cir, 
Rochester Hills, MI 
 (8.4 miles away)
248-853-3131
Experience:
26+ years
Languages Spoken:
English
See accepted insurances

Julie Byrd is a Dermatologist in Rochester Hills, Michigan. Dr. Byrd has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Liver Spots. Her top areas of expertise are Neurocutaneous Melanosis, Actinic Keratosis, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus.

Leonard Cetner
Advanced in Liver Spots
Dr. Leonard Cetner
Dermatology
Advanced in Liver Spots
Dr. Leonard Cetner
Dermatology

Ronald D Kerwin MD PC

6330 Orchard Lake Rd Ste 120, 
West Bloomfield, MI 
 (20.8 miles away)
248-694-6390
Experience:
24+ years
Languages Spoken:
English
See accepted insurances

Leonard Cetner is a Dermatologist in West Bloomfield, Michigan. Dr. Cetner has been practicing medicine for over 24 years and is rated as an Advanced provider by MediFind in the treatment of Liver Spots. His top areas of expertise are Warts, Actinic Keratosis, Neurocutaneous Melanosis, and Giant Congenital Melanocytic Nevus.

VIEW MORE LIVER SPOTS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hamzavi's expertise for a condition
ConditionClose
    • Distinguished
    • Actinic Keratosis
      Dr. Hamzavi is
      Distinguished
      . Learn about Actinic Keratosis.
      See more Actinic Keratosis experts
    • Liver Spots
      Dr. Hamzavi is
      Distinguished
      . Learn about Liver Spots.
      See more Liver Spots experts
    • Universal Acquired Melanosis
      Dr. Hamzavi is
      Distinguished
      . Learn about Universal Acquired Melanosis.
      See more Universal Acquired Melanosis experts
    • Warts
      Dr. Hamzavi is
      Distinguished
      . Learn about Warts.
      See more Warts experts
    • Advanced
    • Basal Cell Skin Cancer
      Dr. Hamzavi is
      Advanced
      . Learn about Basal Cell Skin Cancer.
      See more Basal Cell Skin Cancer experts
    • Cafe-Au-Lait Spots
      Dr. Hamzavi is
      Advanced
      . Learn about Cafe-Au-Lait Spots.
      See more Cafe-Au-Lait Spots experts
    • Cheilitis Glandularis
      Dr. Hamzavi is
      Advanced
      . Learn about Cheilitis Glandularis.
      See more Cheilitis Glandularis experts
    • Comedones
      Dr. Hamzavi is
      Advanced
      . Learn about Comedones.
      See more Comedones experts
    • Contact Dermatitis
      Dr. Hamzavi is
      Advanced
      . Learn about Contact Dermatitis.
      See more Contact Dermatitis experts
    • Dermatitis Herpetiformis
      Dr. Hamzavi is
      Advanced
      . Learn about Dermatitis Herpetiformis.
      See more Dermatitis Herpetiformis experts
    View All 32 Advanced Conditions
    • Experienced
    • Acrogeria, Gottron Type
      Dr. Hamzavi is
      Experienced
      . Learn about Acrogeria, Gottron Type.
      See more Acrogeria, Gottron Type experts
    • Alopecia Areata
      Dr. Hamzavi is
      Experienced
      . Learn about Alopecia Areata.
      See more Alopecia Areata experts
    • Athlete's Foot
      Dr. Hamzavi is
      Experienced
      . Learn about Athlete's Foot.
      See more Athlete's Foot experts
    • Autosomal Recessive Hypotrichosis
      Dr. Hamzavi is
      Experienced
      . Learn about Autosomal Recessive Hypotrichosis.
      See more Autosomal Recessive Hypotrichosis experts
    • Bazex Syndrome
      Dr. Hamzavi is
      Experienced
      . Learn about Bazex Syndrome.
      See more Bazex Syndrome experts
    • Boils
      Dr. Hamzavi is
      Experienced
      . Learn about Boils.
      See more Boils experts
    View All 63 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.